Efficacy of orally administered fluralaner (BravectoTM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs

Abstract Background This laboratory study compared the efficacy of Bravecto™ (fluralaner), formulated as a chewable tablet, with the efficacy of Advocate® (imidacloprid/moxidectin), formulated for topical administration, against naturally acquired generalized demodicosis in dogs. Methods Sixteen dog...

Descrición completa

Detalles Bibliográficos

Principais autores:	Josephus J Fourie, Julian E Liebenberg, Ivan G Horak, Janina Taenzler, Anja R Heckeroth, Regis Frénais
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2015-03-01
Series:	Parasites & Vectors
Assuntos:	Bravecto™ Chewable tablets Fluralaner Advocate® Spot-on Imidacloprid
Acceso en liña:	https://doi.org/10.1186/s13071-015-0775-8
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!